Novel Breast Cancer Susceptibility Locus at 9q31.2: Results of a Genome-Wide Association Study

Olivia Fletcher(Breast Cancer Care), Julian Peto(London School of Hygiene & Tropical Medicine), Minouk J. Schoemaker(Institute of Cancer Research), Nichola Johnson(Institute of Cancer Research), Richard S. Houlston(Institute of Cancer Research), Michael E. Jones(Institute of Cancer Research), Anthony J. Swerdlow(Institute of Cancer Research), Fay J. Hosking(Institute of Cancer Research), Ian Tomlinson(University of Oxford), Gemma Simpson(King's College London), Sarah Chilcott-Burns(Institute of Cancer Research), Alan Ashworth(University of California, San Francisco), Peter Broderick(Institute of Cancer Research), Marta Gut(Centro Nacional de Análisis Genómico), Nick Orr(United States Department of Health and Human Services), Kate Walker(Royal College of Surgeons of England), Katarzyna Tomczyk(Institute of Cancer Research), Diana Zélénika(Centre National de Recherche en Génomique Humaine), Kevin B. Jacobs(Emergent BioSolutions (United States)), Stephen J. Chanock(National Cancer Institute), Simon Heath(Centro Nacional de Análisis Genómico), Gillian Ross(Royal Marsden NHS Foundation Trust), David J. Hunter(Zhujiang Hospital), Ben Coupland(Institute of Cancer Research), Lorna J. Gibson(London School of Hygiene & Tropical Medicine), Mark Lathrop(McGill Genome Centre), Isabel dos‐Santos‐Silva(London School of Hygiene & Tropical Medicine), Jill Williamson(Institute of Cancer Research), Claire Palles(University of Oxford)
JNCI Journal of the National Cancer Institute
January 24, 2011
Cited by 238


Related Papers